CAPITAL MANAGEMENT ASSOCIATES /NY/ IBB — ISHARES NASDAQ BIOTECH

Ownership history in CAPITAL MANAGEMENT ASSOCIATES /NY/  ·  9 quarters on record

AI Ownership Summary

CAPITAL MANAGEMENT ASSOCIATES /NY/ reported ISHARES NASDAQ BIOTECH (IBB) in 9 quarterly 13F filings from 2025 Q4 through 2026 Q1. Peak portfolio weight reached 1.12% in 2026 Q1. The latest visible filing shows IBB at 1.12% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this IBB ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CAPITAL MANAGEMENT ASSOCIATES /NY/'s position in ISHARES NASDAQ BIOTECH, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

IBB was reported at 1.12% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.12% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

IBB stock page CAPITAL MANAGEMENT ASSOCIATES /NY/ fund profile CAPITAL MANAGEMENT ASSOCIATES /NY/ full holdings
How CAPITAL MANAGEMENT ASSOCIATES /NY/ held IBB — position size vs. price
% of Fund (quarterly)    IBB price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 2 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 4,000 — 0% 1.12% $675K 2026-05-04 $170.16
2025 Q4 REDUCED 58.3% +0.1% ❌ 4,000 -5,600 -58.3% 0.99% $675K 2026-02-09 $174.24
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding IBB

As of 2026 Q1 — sorted by position size

Michelson Medical Research Foundation, Inc. 3Y 6.02% McElhenny Sheffield Capital Management, LLC 3Y 5.94% Humankind Investments LLC 3Y 4.82% MARVIN & PALMER ASSOCIATES INC 3Y 7Y 4.41% CUMBERLAND ADVISORS INC 3Y 7Y 4.21% Florin Court Capital LLP 3Y 7Y 4.01% Sofinnova Investments, Inc. 3Y 7Y 3.05% WestEnd Advisors, LLC 3Y 7Y 2.64% Audent Global Asset Management, LLC 3Y 2.56% DAFNA Capital Management LLC 3Y 7Y 2.39%

FAQ About CAPITAL MANAGEMENT ASSOCIATES /NY/ and IBB

These are the practical questions this page is built to answer before you even open the full history table.

How long has CAPITAL MANAGEMENT ASSOCIATES /NY/ reported owning IBB?

CAPITAL MANAGEMENT ASSOCIATES /NY/ reported IBB across 2 quarterly 13F filings, from 2025 Q4 through 2026 Q1.

What was the largest reported IBB position in CAPITAL MANAGEMENT ASSOCIATES /NY/'s portfolio?

The largest reported portfolio weight for IBB was 1.12% in 2026 Q1.

What is the latest reported IBB position on this page?

The most recent filing on this page is 2026 Q1, when CAPITAL MANAGEMENT ASSOCIATES /NY/ reported 4,000 shares, equal to 1.12% of portfolio, with an estimated market value of $675K.

What does the chart on this IBB ownership page compare?

The chart compares CAPITAL MANAGEMENT ASSOCIATES /NY/'s quarterly IBB portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CAPITAL MANAGEMENT ASSOCIATES /NY/ Holdings